(2007). A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension. J Hum Hypertens
(2005). A metaanalytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.
(2002). Agespecific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet
(2007). Aliskiren in combination with hydrochlorothiazide is effective and well tolerated during long-term treatment of hypertension [abstract no.
(2007). Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker. Hypertension
(2008). Aliskiren-hydrochlorothiazide combination for the treatment of hypertension. Expert Rev Cardiovasc Ther
(2006). Aliskiren, a novel renin inhibitor, is well tolerated and has sustained BP-lowering effects alone or in combination with HCTZ during long-term (52 weeks) treatment of hypertension [abstract no.
(2000). Angiotensin II antagonists for hypertension: are there differences in efficacy?
(2002). Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. Hypertension
(2009). Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone. Curr Med Res Opin
(2008). Antihypertensive efficacy of aliskiren/hydrochlorothiazide (HCT) combinations in patients with stage 2 hypertension: subgroup analysis of a randomized, double-blind, factorial trial [abstract no. P-209]. Hypertension
(2007). Antihypertensive efficacy of the direct renin inhibitor when added to hydrochlorothiazide treatment in patients with extreme obesity and hypertension [abstract no.
(1996). Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials
(2009). Blood pressure lowering efficacy of renin inhibitors for primary hypertension: a Cochrane systematic review. J Hum Hypertens
(2009). Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazide alone. J Clin Hypertens (Greenwich)
(2009). Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension. J Renin Angiotensin Aldosterone Syst
(2008). Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
(2007). Direct Renin inhibition with aliskiren in obese patients with arterial hypertension. Hypertension
(2008). Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders.
(2007). Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of
(1999). Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet
(2011). index; DBP – Diastolic blood pressure; F - Female;
(2008). Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis. Curr Med Res Opin
(2009). Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension. Curr Med Res Opin
(2007). Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
(1993). Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
(2002). Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich)
(2007). Updated metaanalytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Clin Drug Investig
(2003). Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ